Insmed Inc (INSM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $150.00
• Market Cap: $31.69B
• EPS: $-6.19
• 52-Week High: $212.75
• 52-Week Low: $60.40

Market Sentiment

Insmed Inc currently has a Bullish sentiment score of 0.24.

About Insmed Inc

Insmed Inc. is a biopharmaceutical company headquartered in Bridgewater, New Jersey, dedicated to developing innovative therapies for rare and serious diseases, with a primary focus on pulmonary and infectious conditions. Its flagship product, ARIKAYCE, targets treatment-refractory Mycobacterium avium complex lung disease, addressing significant unmet medical needs in this area. With a strong commitment to research and development, Insmed is enhancing treatment options and health outcomes for...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Insmed Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does INSM pay dividends?

Insmed Inc (INSM) does not currently pay a regular dividend.

What is INSM's market cap?

Insmed Inc (INSM) has a market capitalization of $31.69B with a current stock price of $150.00.